Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma

BACKGROUND: Papillary renal cell carcinoma (PRCC) can be divided into type 1 (PRCC1) and type 2 (PRCC2) and PRCC2 share a more invasive phenotype and worse prognosis. This study aims to identify potential prognostic and therapeutic biomarkers in PRCC2. METHODS: A cohort from The Cancer Genome Atlas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yue, Tian, Xi, Zhu, Shu-Xuan, Xu, Wen-Hao, Anwaier, Aihetaimujiang, Su, Jia-Qi, Gan, Hua-Lei, Qu, Yuan-Yuan, Zhao, Jian-Yuan, Zhang, Hai-Liang, Ye, Ding-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022194/
https://www.ncbi.nlm.nih.gov/pubmed/36927438
http://dx.doi.org/10.1186/s12957-022-02836-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022194/
https://www.ncbi.nlm.nih.gov/pubmed/36927438
http://dx.doi.org/10.1186/s12957-022-02836-3

Ejemplares similares